The 5th Miami Thyroid Oncology Symposium was held virtually on March 18 and 19, 2022

The 5th Annual Miami Thyroid Oncology Symposium was held virtually on March 18 and 19, 2022. We had more than 600 registrants from more than 20 countries.

Learn More

Miami Cancer Research Center

Mission

Miami Cancer Research Center (MCRC) is a scientific and charitable organization that performs and supports cancer research, organizes educational events and provides support for cancer care at institutional and individual levels.

A Message from Dr. Seza Gulec, MD, President & CEO

A Message from Dr. Seza Gulec, MD, President & CEO

Welcome to our website. Here you will be able to explore news, research and educational opportunities to deepen understanding of the complex world of cancer. It is my hope that together we will find new ways of meeting the needs of patients, families and the medical community facing this difficult disorder.

Read More

Editorial: Surgical Oncology in times of COVID-19

Editorial: Surgical Oncology in times of COVID-19

While COVID-19 infection continues to spread worldwide at an exponential pace, surgical oncologists and other cancer specialists need to adapt to the new situation to keep providing the same quality and cutting-edge care to our patients

Learn More

Translational Research

MCRCI’s main interest is developing theranostic strategies for solid tumors through translational research. Our translational research tools for theranostics are molecular imaging and genomic profiling. Patient-specific (individualized) treatment protocols are generated for surgical and nuclear medicine treatments.

Learn More

News & Events

OCCPR Leading the War Against Cancer in the Next Battlefield: Proteomics and Protegenomics

OCCPR Leading the War Against Cancer in the Next Battlefield: Proteomics and Protegenomics

Improve the prevention, early detection, diagnosis, and treatment of cancer, by enhancing the understanding of the molecular mechanisms of cancer and advancing proteome and proteogenomic science and technology development.

Read More

The Next Horizon in Precision Oncology

The Next Horizon in Precision Oncology


Proteogenomics characterizes tumors molecularly, makes the diagnosis more accurate, and can potentially impact cancer treatment, improving outcomes in our patients.

Read More

Innovation

ThyroSeq® presented the results of its prospective, double-blind, multi-center international study today, at the 87th Annual Meeting of the American Thyroid Association (ATA) in Victoria, BC, Canada.

Read More